P51451 (BLK_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Tyrosine-protein kinase Blk EC=2.7.10.2 Alternative name(s): B lymphocyte kinase p55-Blk | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 505 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Non-receptor tyrosine kinase involved in B-lymphocyte development, differentiation and signaling. B-cell receptor (BCR) signaling requires a tight regulation of several protein tyrosine kinases and phosphatases, and associated coreceptors. Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation. Signaling through BLK plays an important role in transmitting signals through surface immunoglobulins and supports the pro-B to pre-B transition, as well as the signaling for growth arrest and apoptosis downstream of B-cell receptor. Specifically binds and phosphorylates CD79A at 'Tyr-188'and 'Tyr-199', as well as CD79B at 'Tyr-196' and 'Tyr-207'. Phosphorylates also the immunoglobulin G receptors FCGR2A, FCGR2B and FCGR2C. With FYN and LYN, plays an essential role in pre-B-cell receptor (pre-BCR)-mediated NF-kappa-B activation. Contributes also to BTK activation by indirectly stimulating BTK intramolecular autophosphorylation. In pancreatic islets, acts as a modulator of beta-cells function through the up-regulation of PDX1 and NKX6-1 and consequent stimulation of insulin secretion in response to glucose. Ref.7 Ref.10 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Enzyme regulation | Antibody-mediated surface engagement of the B-cell antigen receptor (BCR) which results in the phosphorylation of BLK on tyrosine residues, stimulates the enzymatic activity By similarity. |
| Subunit structure | Interacts with CBL (via SH2 domain). Interacts with CD79A and CD79B (via SH2 domain) By similarity. Ref.6 |
| Subcellular location | Cell membrane; Lipid-anchor By similarity. Note: Present and active in lipid rafts. Membrane location is required for the phosphorylation of CD79A and CD79B By similarity. Ref.9 |
| Tissue specificity | Expressed in lymphatic organs, pancreatic islets, Leydig cells, striate ducts of salivary glands and hair follicles. Ref.10 |
| Induction | Expression is under the control of NF-kappa-B as well as the B-cell specific transcription factors PAX5 and EBF1. Ref.8 |
| Post-translational modification | Phosphorylated on tyrosine residues after antibody-mediated surface engagement of the B-cell antigen receptor (BCR) By similarity. Ref.9 Ubiquitination of activated BLK by the UBE3A ubiquitin protein ligase leads to its degradation by the ubiquitin-proteasome pathway By similarity. |
| Involvement in disease | Maturity-onset diabetes of the young 11 (MODY11) [MIM:613375]: A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease. |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. SRC subfamily. Contains 1 protein kinase domain. Contains 1 SH2 domain. Contains 1 SH3 domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Polymorphism |
| Disease | Diabetes mellitus |
| Domain | SH2 domain SH3 domain |
| Ligand | ATP-binding Nucleotide-binding |
| Molecular function | Kinase Transferase Tyrosine-protein kinase |
| PTM | Lipoprotein Myristate Phosphoprotein Ubl conjugation |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | B cell receptor signaling pathway Inferred from direct assay PubMed 876631. Source: UniProtKB intracellular protein kinase cascadeTraceable author statement PubMed 2404338. Source: ProtInc positive regulation of insulin secretionInferred from mutant phenotype Ref.10. Source: UniProtKB |
| Cellular_component | plasma membrane Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular_function | ATP binding Inferred from electronic annotation. Source: UniProtKB-KW non-membrane spanning protein tyrosine kinase activityInferred from direct assay PubMed 876631. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 505 | 505 | Tyrosine-protein kinase Blk | PRO_0000088061 | |||||
Regions | |||||||||
| Domain | 58 – 118 | 61 | SH3 | ||||||
| Domain | 124 – 220 | 97 | SH2 | ||||||
| Domain | 241 – 494 | 254 | Protein kinase | ||||||
| Nucleotide binding | 247 – 255 | 9 | ATP By similarity | ||||||
Sites | |||||||||
| Active site | 360 | 1 | Proton acceptor By similarity | ||||||
| Binding site | 269 | 1 | ATP By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 389 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||
| Lipidation | 2 | 1 | N-myristoyl glycine By similarity | ||||||
Natural variations | |||||||||
| Natural variant | 48 | 1 | T → I. Ref.12 Corresponds to variant rs35339715 [ dbSNP | Ensembl ]. | VAR_041672 | |||||
| Natural variant | 71 | 1 | A → T Associated with MODY11; reduces the enhancing effect of BLK on insulin secretion; reduces the inducing effect of BLK on the expression of PDX1 and NKX6-1; found as somatic mutation in a colorectal adenocarcinoma sample. Ref.10 Ref.12 Corresponds to variant rs55758736 [ dbSNP | Ensembl ]. | VAR_041673 | |||||
Experimental info | |||||||||
| Sequence conflict | 287 | 1 | V → M in CAA83965. Ref.1 | ||||||
| Sequence conflict | 407 | 1 | I → Y in AAB33265. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk." Islam K.B., Rabbani H., Larsson C., Sanders R., Smith C.I. J. Immunol. 154:1265-1272(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Molecular cloning and chromosomal localization of the human homologue of a B-lymphocyte specific protein tyrosine kinase (blk)." Drebin J.A., Hartzell S.W., Griffin C., Campbell M.J., Niederhuber J.E. Oncogene 10:477-486(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Spleen. |
| [4] | Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Blood and Lymph. |
| [6] | "The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor." Donovan J.A., Wange R.L., Langdon W.Y., Samelson L.E. J. Biol. Chem. 269:22921-22924(1994) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CBL. |
| [7] | "In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation." Bewarder N., Weinrich V., Budde P., Hartmann D., Flaswinkel H., Reth M., Frey J. Mol. Cell. Biol. 16:4735-4743(1996) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF FCGR2A; FCGR2B AND FCGR2C. |
| [8] | "Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development." Akerblad P., Sigvardsson M. J. Immunol. 163:5453-5461(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [9] | "IgA Fc receptor (FcalphaR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts." Lang M.L., Chen Y.W., Shen L., Gao H., Lang G.A., Wade T.K., Wade W.F. Biochem. J. 364:517-525(2002) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION, SUBCELLULAR LOCATION. |
| [10] | "Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction." Borowiec M., Liew C.W., Thompson R., Boonyasrisawat W., Hu J., Mlynarski W.M., El Khattabi I., Kim S.H., Marselli L., Rich S.S., Krolewski A.S., Bonner-Weir S., Sharma A., Sale M., Mychaleckyj J.C., Kulkarni R.N., Doria A. Proc. Natl. Acad. Sci. U.S.A. 106:14460-14465(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION AS REGULATOR OF INSULIN SECRETION, TISSUE SPECIFICITY, INVOLVEMENT IN MODY11, VARIANT THR-71, CHARACTERIZATION OF VARIANT THR-71. |
| [11] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [12] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] ILE-48; THR-71 AND THR-71. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | Z33998 mRNA. Translation: CAA83965.1. S76617 mRNA. Translation: AAB33265.1. AK313751 mRNA. Translation: BAG36491.1. CH471157 Genomic DNA. Translation: EAW65617.1. BC007371 mRNA. Translation: AAH07371.1. BC032413 mRNA. Translation: AAH32413.1. |
| IPI | IPI00941870. |
| PIR | I37206. |
| RefSeq | NP_001706.2. NM_001715.2. |
| UniGene | Hs.146591. |
3D structure databases | |
| ProteinModelPortal | P51451. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P51451. 2 interactions. |
| MINT | MINT-1494192. |
| STRING | 9606.ENSP00000259089. |
PTM databases | |
| PhosphoSite | P51451. |
Polymorphism databases | |
| DMDM | 158936749. |
Proteomic databases | |
| PaxDb | P51451. |
| PRIDE | P51451. |
Protocols and materials databases | |
| DNASU | 640. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000259089; ENSP00000259089; ENSG00000136573. |
| GeneID | 640. |
| KEGG | hsa:640. |
| UCSC | uc003wty.3. human. |
Organism-specific databases | |
| CTD | 640. |
| GeneCards | GC08P011388. |
| H-InvDB | HIX0007315. HIX0168887. |
| HGNC | HGNC:1057. BLK. |
| HPA | CAB005093. |
| MIM | 191305. gene. 613375. phenotype. |
| neXtProt | NX_P51451. |
| Orphanet | 552. MODY syndrome. |
| PharmGKB | PA25368. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0515. |
| HOGENOM | HOG000233858. |
| HOVERGEN | HBG008761. |
| InParanoid | P51451. |
| KO | K08890. |
| PhylomeDB | P51451. |
Enzyme and pathway databases | |
| BRENDA | 2.7.10.2. 2681. |
| Pathway_Interaction_DB | alphasynuclein_pathway. Alpha-synuclein signaling. amb2_neutrophils_pathway. amb2 Integrin signaling. pi3kcipathway. Class I PI3K signaling events. epha_fwdpathway. EPHA forward signaling. ephrinbrevpathway. Ephrin B reverse signaling. glypican_1pathway. Glypican 1 network. pdgfrbpathway. PDGFR-beta signaling pathway. p38alphabetapathway. Regulation of p38-alpha and p38-beta. ptp1bpathway. Signaling events mediated by PTP1B. txa2pathway. Thromboxane A2 receptor signaling. |
| Reactome | REACT_6900. Immune System. |
| SignaLink | P51451. |
Gene expression databases | |
| ArrayExpress | P51451. |
| Bgee | P51451. |
| CleanEx | HS_BLK. |
| Genevestigator | P51451. |
| GermOnline | ENSG00000136573. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.30.505.10. 1 hit. |
| InterPro | IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR000980. SH2. IPR001452. SH3_domain. IPR020635. Tyr_kinase_cat_dom. [Graphical view] |
| Pfam | PF07714. Pkinase_Tyr. 1 hit. PF00017. SH2. 1 hit. PF00018. SH3_1. 1 hit. [Graphical view] |
| PRINTS | PR00401. SH2DOMAIN. PR00452. SH3DOMAIN. PR00109. TYRKINASE. |
| SMART | SM00252. SH2. 1 hit. SM00326. SH3. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] |
| SUPFAM | SSF56112. Kinase_like. 1 hit. SSF50044. SH3. 1 hit. |
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. False negative. PS50001. SH2. 1 hit. PS50002. SH3. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | P51451. |
| ChEMBL | CHEMBL2250. |
| ChiTaRS | BLK. human. |
| GenomeRNAi | 640. |
| NextBio | 2596. |
| SOURCE | Search... |
Entry information
| Entry name | BLK_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P51451 Secondary accession number(s): Q16291, Q96IN1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
